Bodal Chemicals Earnings Call Transcript: Key Takeaways
Consolidated Q2 FY27 revenue ₹884 Cr (+77%), EBITDA ₹128 Cr (14.4% margin), PAT ₹81 Cr. Price-led China-linked spike; receivables and working capital rising, debt flat.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Consolidated Q2 FY27 revenue ₹884 Cr (+77%), EBITDA ₹128 Cr (14.4% margin), PAT ₹81 Cr. Price-led China-linked spike; receivables and working capital rising, debt flat.
H1FY27 consolidated revenue Rs15,991mn (+67% YoY), EBITDA Rs2,027mn (12.7% margin), PAT Rs1,118mn. Q2 posted record revenue and a 14.4% EBITDA margin.
Bodal Chemicals Ltd reported revenue from operations of ₹863.4 Cr (+79.7% YoY) and net profit of ₹81.4 Cr (+1256.7% YoY) for Q2 FY27.
Bodal Chemicals Limited has intimated a board meeting on 03 November 2026 to consider unaudited standalone and consolidated quarterly and half-year results, plus any other business. The trading window reopens 06 November 2026.
Bodal Chemicals Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Bodal Chemicals Limited conducted its 40th Annual General Meeting on September 25, 2026. The meeting successfully passed all proposed resolutions with the requisite majority.
Bodal Chemicals reported an inter-se promoter group transfer of 1,70,000 equity shares. Ramesh D Patel sold the stake to Ankit S. Patel for Rs. 3.39 Crore.
Ramesh D Patel, a member of the promoter group, sold 1,70,000 equity shares (0.13%) of Bodal Chemicals Ltd. The transaction occurred off-market on September 29, 2026.
Promoter Ankit S. Patel acquired 1,70,000 equity shares of Bodal Chemicals Ltd through an open market (inter-se) transaction. This increases his stake from 5.77% to 5.90%.
Promoter Ramesh D Patel sold 1,70,000 equity shares of Bodal Chemicals Ltd via open market. This transaction reduced the promoter's stake from 3.93% to 3.79%.
Bodal Chemicals Ltd conducted its 40th Annual General Meeting on September 25, 2026. Key business included adopting FY26 financial statements and ratifying auditor remuneration.
Bodal Chemicals Ltd. clarifies that news regarding a potential merger circulating on social media is false and baseless. The company confirms no such proposal exists.
Ashokkumar Giriraj Bansal acquired 1,75,000 shares of Bodal Chemicals Ltd via open market purchases. Post-acquisition, his total shareholding increased to 5.01%.
Bodal Chemicals Limited clarified that recent share price and volume fluctuations are purely market-driven. The company confirmed no undisclosed price-sensitive information exists that would impact trading behavior.
Bodal Chemicals Limited has filed its Annual Report for the financial year 2025-26. The 40th Annual General Meeting is scheduled for September 25, 2026.
Bodal Chemicals Limited has scheduled its 40th Annual General Meeting on September 25, 2026, through video conferencing to transact ordinary and special business.
Bodal Chemicals Limited will hold its 40th Annual General Meeting on September 25, 2026. The company set September 18, 2026, as the record date for e-voting.